...
首页> 外文期刊>Journal of proteome research >Quantitation of 87 Proteins by nLC-MRM/MS in Human Plasma: Workflow for Large-Scale Analysis of Biobank Samples
【24h】

Quantitation of 87 Proteins by nLC-MRM/MS in Human Plasma: Workflow for Large-Scale Analysis of Biobank Samples

机译:通过人血浆NLC-MRM / MS定量87个蛋白质:用于BIOBANK样品的大规模分析的工作流程

获取原文
获取原文并翻译 | 示例
           

摘要

A multiple reaction monitoring (MRM) assay was developed for precise quantitation of 87 plasma proteins including the three isoforms of apolipoprotein E (APOE) associated with cardiovascular diseases using nanoscale liquid chromatography separation and stable isotope dilution strategy. The analytical performance of the assay was evaluated and we found an average technical variation of 4.7% in 4-5 orders of magnitude dynamic range (approximate to 0.2 mg/L to 4.5 g/L) from whole plasma digest. Here, we report a complete workflow, including sample processing adapted to 96-well plate format and normalization strategy for large-scale studies. To further investigate the MS-based quantitation the amount of six selected proteins was measured by routinely used clinical chemistry assays as well and the two methods showed excellent correlation with high significance (p-value < 10e-5) for the six proteins, in addition for the cardiovascular predictor factor, APOB: APOA1 ratio (r = 0.969, p-value < 10e-5). Moreover, we utilized the developed assay for screening of biobank samples from patients with myocardial infarction and performed the comparative analysis of patient groups with STEMI (ST- segment elevation myocardial infarction), NSTEMI (non ST- segment elevation myocardial infarction) and type-2 AMI (type-2 myocardial infarction) patients.
机译:开发了多反应监测(MRM)测定以确切定量87个血浆蛋白,包括使用纳米级液相色谱分离和稳定同位素稀释策略与心血管疾病相关的载脂蛋白E(ApoE)的三种同种型。评估了测定的分析性能,并发现了4-5个幅度动态范围(大约0.2mg / L至4.5g / L)的4.7%的平均技术变异来自整个血浆消化。在这里,我们报告了一个完整的工作流程,包括适应于96孔板格式的样本处理和大规模研究的正常化策略。为了进一步研究基于MS的定量,通过常规使用临床化学测定来测量六种选定蛋白的量,并且两种方法表现出六种蛋白质的高意义(p值<10e-5)的优异相关性对于心血管预测因子,apob:apoa1比率(r = 0.969,p值<10e-5)。此外,我们利用开发的测定来筛查来自心肌梗塞患者的生物安样本,并对患者组进行患者组(ST-段抬高心肌梗死),nstemi(非ST-段升高心肌梗死)和2型AMI(2型心肌梗死)患者。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号